Delivery Order SPE2DB25D3201-SPE2DB25FNVUS
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $22,046.06 delivery order to AmerisourceBergen Drug Corp for Polivy 140 mg vials, with an ultimate completion date of September 5, 2025. This competitive award (non-set-aside) represents a firm fixed-price contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a $22,046.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Polivy 140 mg vials. This is a non-set-aside, competitively awarded contract with a completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 140 mg vials of the drug Polivy, with a ceiling value of $31,362.96 and an ultimate completion date of September 17, 2024. This award is not associated with a set-aside program. AmerisourceBergen, through its extensive supply chain network, will provide this critical...
- AmerisourceBergen Drug Corp was awarded a $58,964.20 delivery order on July 23, 2025, for the supply of Polivy 140 mg vials under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This is a competitive, non-set-aside delivery order with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Polivy is a specialized pharmaceutical product used in hematologic malignancy...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $20,908.66, is for the delivery of POLIVY 140 MG vials to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,046.06, is a Firm Fixed Price Delivery Order to provide POLIVY 140 MG VIALS to support military healthcare programs. The contract has an ultimate completion date of March 17, 2025 and was awarded on February 24, 2025. This award is not designated as a set-aside contract. Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of POLIVY 140 MG VIALS, a type of medical product. The contract has a firm fixed price of $44,092.12 and a completion date of July 16, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,304.48 to AmerisourceBergen Drug Corp on July 18, 2025, for pharmaceutical products and medical supplies under the Pharmaceutical PV Division. The contract, designated as a non-set-aside competitive award, has an ultimate completion date of July 21, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,686.61 to AmerisourceBergen Drug Corp on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the prime contractor's Corporate Office division, located in Conshohocken, Pennsylvania. The contract falls under the Pharmaceutical Prime Vendor Global Program framework, which supports federal medical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,657.32 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. AmerisourceBergen Drug Corp, a major healthcare solutions provider and pharmaceutical distributor,...